Literature DB >> 31062058

Current controversy, confusion, and imprecision in the use and interpretation of rectal MRI.

Marc J Gollub1, Chandana Lall2, Neeraj Lalwani3, Michael H Rosenthal4.   

Abstract

There has been a rapid increase in the utilization of MRI in rectal cancer staging in the USA essentially replacing endorectal ultrasound and mimicking the trend in Europe seen in the 1990s and 2000s. Accompanying this trend, there is a demand, and recognized need, for greater precision and clarification of confusing, misunderstood and poorly understood concepts, facts, statements and nomenclature regarding rectal cancer and the use of pelvic MRI for diagnosis. As such, this Review, part evidence-based and part expert opinion, will attempt to elucidate and clarify several concepts the authors have encountered in 25 years of imaging rectal cancer, focusing on MRI.

Entities:  

Keywords:  Opinion; Rectal Cancer; Restaging; Staging

Mesh:

Year:  2019        PMID: 31062058      PMCID: PMC7365137          DOI: 10.1007/s00261-019-01996-3

Source DB:  PubMed          Journal:  Abdom Radiol (NY)


  60 in total

1.  Neoadjuvant (Chemo)radiotherapy With Total Mesorectal Excision Only Is Not Sufficient to Prevent Lateral Local Recurrence in Enlarged Nodes: Results of the Multicenter Lateral Node Study of Patients With Low cT3/4 Rectal Cancer.

Authors:  Atsushi Ogura; Tsuyoshi Konishi; Chris Cunningham; Julio Garcia-Aguilar; Henrik Iversen; Shigeo Toda; In Kyu Lee; Hong Xiang Lee; Keisuke Uehara; Peter Lee; Hein Putter; Cornelis J H van de Velde; Geerard L Beets; Harm J T Rutten; Miranda Kusters
Journal:  J Clin Oncol       Date:  2018-11-07       Impact factor: 44.544

2.  The influence of endorectal filling on rectal cancer staging with MRI.

Authors:  Rutger Ch Stijns; Tom Wj Scheenen; Johannes Hw de Wilt; Jurgen J Fütterer; Regina Gh Beets-Tan
Journal:  Br J Radiol       Date:  2018-06-14       Impact factor: 3.039

3.  Impact of the new AJCC staging system and adjuvant treatment in rectal cancer.

Authors:  Shin Ae Lee; Hyuk-Chan Kwon; Min Ah Park; Chang Kil Jung; Sung-Hyun Kim; Ki-Jae Park; Hong-Jo Choi; Hyung-Sik Lee; Mee Sook Roh; Jae-Seok Kim; Hyo-Jin Kim
Journal:  Cancer Res Treat       Date:  2004-04-30       Impact factor: 4.679

4.  Colorectal Cancer Incidence Patterns in the United States, 1974-2013.

Authors:  Rebecca L Siegel; Stacey A Fedewa; William F Anderson; Kimberly D Miller; Jiemin Ma; Philip S Rosenberg; Ahmedin Jemal
Journal:  J Natl Cancer Inst       Date:  2017-08-01       Impact factor: 13.506

5.  Distance between the rectal wall and mesorectal fascia measured by MRI: Effect of rectal distension and implications for preoperative prediction of a tumour-free circumferential resection margin.

Authors:  A Slater; S Halligan; S A Taylor; M Marshall
Journal:  Clin Radiol       Date:  2006-01       Impact factor: 2.350

6.  JOURNAL CLUB: Preoperative MRI Evaluation of Primary Rectal Cancer: Intrasubject Comparison With and Without Rectal Distention.

Authors:  Feng Ye; Hongmei Zhang; Xiao Liang; Han Ouyang; Xinming Zhao; Chunwu Zhou
Journal:  AJR Am J Roentgenol       Date:  2016-05-04       Impact factor: 3.959

7.  Local recurrence after complete clinical response and watch and wait in rectal cancer after neoadjuvant chemoradiation: impact of salvage therapy on local disease control.

Authors:  Angelita Habr-Gama; Joaquim Gama-Rodrigues; Guilherme P São Julião; Igor Proscurshim; Charles Sabbagh; Patricio B Lynn; Rodrigo O Perez
Journal:  Int J Radiat Oncol Biol Phys       Date:  2014-02-01       Impact factor: 7.038

8.  Comparison of tumor regression grade systems for locally advanced rectal cancer after multimodality treatment.

Authors:  Atthaphorn Trakarnsanga; Mithat Gönen; Jinru Shia; Garrett M Nash; Larissa K Temple; José G Guillem; Philip B Paty; Karyn A Goodman; Abraham Wu; Marc Gollub; Neil Segal; Leonard Saltz; Julio Garcia-Aguilar; Martin R Weiser
Journal:  J Natl Cancer Inst       Date:  2014-09-22       Impact factor: 13.506

9.  Value of adding dynamic contrast-enhanced MRI visual assessment to conventional MRI and clinical assessment in the diagnosis of complete tumour response to chemoradiotherapy for rectal cancer.

Authors:  Marc J Gollub; Ivana Blazic; Seth Felder; Andrea Knezevic; Mithat Gonen; Julio Garcia-Aguilar; P Phillip Paty; J Joshua Smith
Journal:  Eur Radiol       Date:  2018-09-21       Impact factor: 5.315

10.  A rectal cancer feasibility study with an embedded phase III trial design assessing magnetic resonance tumour regression grade (mrTRG) as a novel biomarker to stratify management by good and poor response to chemoradiotherapy (TRIGGER): study protocol for a randomised controlled trial.

Authors:  Nick J Battersby; Mit Dattani; Sheela Rao; David Cunningham; Diana Tait; Richard Adams; Brendan J Moran; Shelize Khakoo; Paris Tekkis; Shahnawaz Rasheed; Alex Mirnezami; Philip Quirke; Nicholas P West; Iris Nagtegaal; Irene Chong; Anguraj Sadanandam; Nicola Valeri; Karen Thomas; Michelle Frost; Gina Brown
Journal:  Trials       Date:  2017-08-29       Impact factor: 2.279

View more
  2 in total

1.  Retrospective evaluation of national MRI reporting quality for lateral lymph nodes in rectal cancer patients and concordance with prospective re-evaluation following additional training.

Authors:  Tania C Sluckin; Sanne-Marije J A Hazen; Karin Horsthuis; Regina G H Beets-Tan; Corrie A M Marijnen; Pieter J Tanis; Miranda Kusters
Journal:  Insights Imaging       Date:  2022-10-20

2.  An MRI-based pelvimetry nomogram for predicting surgical difficulty of transabdominal resection in patients with middle and low rectal cancer.

Authors:  Yuan Yuan; Dafeng Tong; Minglu Liu; Haidi Lu; Fu Shen; Xiaohui Shi
Journal:  Front Oncol       Date:  2022-07-25       Impact factor: 5.738

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.